|
| | Publication Year | Title | Author(s) |
| 1 | 7-Dec-2023 | Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML:a randomized, placebo-controlled study by the ALLG. | Loo, Sun; Roberts, Andrew W; Anstee, Natasha S; Kennedy, Glen A; He, Simon Zhao-Xiong; Schwarer, Anthony P ; Enjeti, Anoop Kumar; D'Rozario, James; Marlton, Paula; Bilmon, Ian; Taper, John M; Cull, Gavin; Tiley, Campbell; Verner, Emma; Hahn, Uwe; Hiwase, Devendra K; Iland, Harry J; Murphy, Nicholas Edward; Ramanathan, Sundra; Reynolds, John; Ong, Doen Ming; Tiong, Ing Soo; Wall, Meaghan; Murray, Michael; Rawling, Tristan; Leadbetter, Joanna; Rowley, Leesa; Latimer, Maya; Yuen, Sam L S; Ting, Stephen B; Fong, Chun Yew ; Morris, Kirk Lachlan; Bajel, Ashish; Seymour, John F; Levis, Mark J; Wei, Andrew H |
| 2 | 1-Sep-2023 | Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention. | Shanmuganathan, Naranie; Wadham, Carol; Shahrin, NurHezrin; Feng, Jinghua; Thomson, Daniel; Wang, Paul; Saunders, Verity; Kok, Chung Hoow; King, Rob M; Kenyon, Rosalie R; Lin, Ming; Pagani, Ilaria S; Ross, David M; Yong, Agnes S M; Grigg, Andrew P ; Mills, Anthony K; Schwarer, Anthony P ; Braley, Jodi; Altamura, Haley; Yeung, David T; Scott, Hamish S; Schreiber, Andreas W; Hughes, Timothy P; Branford, Susan |
| 3 | Jan-2023 | Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial. | Watts, Justin M; Baer, Maria R; Yang, Jay; Prebet, Thomas; Lee, Sangmin; Schiller, Gary J; Dinner, Shira N; Pigneux, Arnaud; Montesinos, Pau; Wang, Eunice S; Seiter, Karen P; Wei, Andrew H; De Botton, Stephane; Arnan, Montserrat; Donnellan, Will; Schwarer, Anthony P ; Récher, Christian; Jonas, Brian A; Ferrell, P Brent; Marzac, Christophe; Kelly, Patrick; Sweeney, Jennifer; Forsyth, Sanjeev; Guichard, Sylvie M; Brevard, Julie; Henrick, Patrick; Mohamed, Hesham; Cortes, Jorge E |
| 4 | 26-Apr-2021 | The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia. | Rees, Matthew J ; Wu, Simon; Mokoonlall, Mridula; Dix, Caroline H K; Bryant, Christian E; D'Rozario, James; Schwarer, Anthony P ; Grigg, Andrew P ; Tiong, Ing S |
| 5 | Mar-2021 | Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia. | Tiong, Ing S ; Dillon, Richard; Ivey, Adam; Teh, Tse-Chieh; Nguyen, Phillip; Cummings, Nicholas; Taussig, David C; Latif, Annie-Louise; Potter, Nicola E; Runglall, Manohursingh; Russell, Nigel H; Raj, Kavita; Schwarer, Anthony P ; Fong, Chun Yew ; Grigg, Andrew P ; Wei, Andrew H |
| 6 | 2021 | Outcomes of non-myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission. | Nguyen, Phillip C; Manos, Kate ; Fong, Chun Y; Schwarer, Anthony P ; Tiong, Ing S ; Wei, Andrew H; Kliman, David; Curtis, David J |
| 7 | 2021 | Acute graft-versus-host disease associated cerebellitis as the cause of pyrexia of unknown origin detected with 18F-FDG-PET/CT. | Jewell, Kerry E; Kuzich, James A; Lee, Sze Ting ; Trethowan, Rebecca; Macdonell, Richard A L ; Schwarer, Anthony P |
Loading...
2
0
20
0
false